Source: PR Newswire

Press Release: NEB : New England Biolabs Launches EM-seq v2, an updated kit for more sensitive detection of 5mC and 5hmC

/PRNewswire/ -- New England Biolabs (NEB®) announces the launch of EM-seq v2, a high-performance enzyme-based alternative to bisulfite sequencing for the...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Salvatore Russello's photo - CEO of NEB

CEO

Salvatore Russello

CEO Approval Rating

82/100

Read more